immatics biotechnologies GmbH (IMTXW) — Cash Flow Quality Index
immatics biotechnologies GmbH (IMTXW) has a Cash Flow Quality Index of -1.30x as of December 2024. Operating cash flow of $-58.48 Million is below net income of $44.86 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of immatics biotechnologies GmbH to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
immatics biotechnologies GmbH Cash Flow Quality Index (2022–2024)
Historical Cash Flow Quality Index for immatics biotechnologies GmbH across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check immatics biotechnologies GmbH total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for immatics biotechnologies GmbH (2022–2024)
Year-by-year earnings quality comparison for immatics biotechnologies GmbH. For live market cap and the full company financial profile, see market value of immatics biotechnologies GmbH.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -10.38x | $-158.03 Million | $15.22 Million | ▼ -489.1% |
| 2022 | 2.67x | $100.13 Million | $37.51 Million | — |